Results 1 to 10 of about 131,343 (196)

Nonalcoholic Fatty Liver Disease [PDF]

Canadian Journal of Gastroenterology and Hepatology, 2018
According to the papers published in this special issue, NAFLD is a serious problem, which each author from their own aspect tried to clarify. Regarding the fact that NAFLD is rarely isolated and that it is correlated with obesity, diabetes type 2, polycystic ovarian syndrome, obstructive sleep apnea, and some cognitive deficits, its pathophysiology ...
Branka Filipović, Alastair Forbes, Bojan Tepeš, Dan L. Dumitraşcu   +3 more
doaj   +7 more sources

Nonalcoholic fatty liver disease

Annals of Hepatology, 2004
Nonalcoholic fatty liver disease is a clinicopathologic syndrome that encompasses several clinical entities. The spectrum of conditions ranges from simple steatosis to steatohepatitis, fibrosis and end stage liver disease.
Lafaine M. Grant, Mauricio Lisker-Melman
doaj   +5 more sources

Nonalcoholic fatty liver disease

Journal of Lipid Research, 2009
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States and, indeed, worldwide. It has become a global public health issue.
Sandra K. Erickson
doaj   +3 more sources

Nonalcoholic fatty liver disease [PDF]

Nature Reviews Disease Primers, 2015
Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are additional findings of portal and lobular inflammation and hepatocyte injury (which characterize nonalcoholic steatohepatitis (NASH)).
Brunt, Elizabeth M, Wong, Vincent W. S., Nobili, Valerio, Day, Christopher P., Sookoian, Silvia, Maher, Jacquelyn J., BUGIANESI, Elisabetta, Sirlin, Claude B., Neuschwander Tetri, Brent A., Rinella, Mary E.   +9 more
  +19 more sources

Nonalcoholic Fatty Liver Disease [PDF]

Gastroenterology Clinics of North America, 2020
AbstractNonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of the metabolic syndrome (MetS) and comprises one of the largest health threats of the twenty-first century. In this chapter, we review the current state of knowledge of NAFLD and underline the striking similarities with atherosclerosis.
Ding, Lingling, Oligschlaeger, Yvonne, Shiri-Sverdlov, Ronit, Houben, Tom   +3 more
openaire   +5 more sources

Nonalcoholic fatty liver disease

Canadian Medical Association Journal, 2023
Management of nonalcoholic fatty liver disease (NAFLD) is crucial for type 2 diabetes (T2D) remission because they are linked through the common pathophysiology of insulin resistance and lipotoxicity. One in three patients with T2D has nonalcoholic steatohepatitis leading to fibrosis, cirrhosis, and hepatocellular carcinoma.
Bebawi, Emmanuel, Takla, Mark, Leonard, Jennifer   +2 more
openaire   +4 more sources

Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease

Kidney Diseases, 2022
Background: Nonalcoholic fatty liver disease and chronic kidney disease are major public health issues worldwide. The clinical burden of nonalcoholic fatty liver disease is not only confined to liver-related morbidity and mortality, but it also includes ...
Huixia Liu, Chun Zhang, Jing Xiong
doaj   +1 more source

Nonalcoholic Fatty Liver Disease [PDF]

North Carolina Medical Journal, 2016
Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is the leading cause of chronic liver disease. Treatments target lifestyle modification and improvement of underlying risk factors. Noninvasive biomarkers for diagnosis and staging of NAFLD and safe, cost-effective treatments for patients with nonalcoholic ...
Tyler, Thrasher, Manal F, Abdelmalek
openaire   +4 more sources

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2022
Aim: present clinical guidelines, aimed at general practitioners, gastroenterologists, cardiologists, endocrinologists, comprise up-to-date methods of diagnosis and treatment of non-alcoholic fatty liver disease.Key points.
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova   +22 more
doaj   +1 more source

Nonalcoholic Fatty Liver Disease

The Korean Journal of Gastroenterology, 2010
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, and is commonly associated with obesity. The spectrum of NAFLD ranges from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Fructose ingestion, visceral obesity, and metabolic syndrome are risk factors for liver fibrosis. NAFLD is characterized by
Kathryn, Law, Elizabeth M, Brunt
  +7 more sources